About Baheal
Baheal Medical Group is a healthcare industry group driven by scientific and technological innovations, with core businesses including medical innovation incubation, manufacturing, and commercialization. Drawing on deep clinical insights, Baheal has established a platform to transform scientific research into practical applications. By partnering with national research institutions, Baheal focuses on the investment and incubation of groundbreaking innovations rooted in fundamental biological research, with the potential for First-in-Class achievements. Baheal Medical Group's listed company, Baheal Pharma, is an industrialization platform with innovative brand-building capabilities, and continues to advance the translation of medical innovations into clinical practice. Today, Baheal has built a diversified portfolio across bone health, anti-organ fibrosis, and brain metastases, and has successfully incubated multiple category-leading brands.

Social Responsibility

Innovation Incubation Platform
Baheal constantly strives to discover innovations with clinical applicability, to develop pharmaceutical brand commercialization platform and services with China's proprietary intellectual property rights, and to leverage technological innovation to optimize healthcare practices.
Back to Top